# Entrada Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 18, 2025

- Company: [Entrada Therapeutics, Inc.](/companies/trda.md) (CIK 1689375)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-18
- Accepted by EDGAR: Nov 18, 2025, 16:38 ET
- Period: not reported
- Accession: 0001674324-25-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1689375/000167432425000005/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1689375/000167432425000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1689375/000167432425000005/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001674324-25-000005. Last ingested by Listed: Nov 5, 2026, 11:57 ET. No prices; not investment advice.